Liver Preservation Systems Market - By Type: Static Cold Storage, Machine Perfusion. By Application: Transplantation, Research. By End-user: Hospitals, Research Institutions, Organ Procurement Organizations. By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
The Global Liver Preservation Systems Market is undergoing a technological renaissance, driven by critical organ shortages, advancements in perfusion technology, and a growing demand for transplantable organs. Valued at USD 230 million in 2023, the market is projected to grow at a CAGR of 9.8%, reaching USD 480 million by 2031. This comprehensive analysis examines the paradigm shift from static cold storage to dynamic preservation methods that significantly improve transplant outcomes and expand the donor pool.
Three key trends are reshaping the market: the validation of normothermic perfusion systems, the development of organ repair technologies during preservation, and the use of AI-driven viability assessment tools. The report highlights comparisons of preservation techniques, clinical outcomes, and the economic effects of extended preservation times. It also focuses on the growing use of marginal donor organs and the expedited regulatory pathways for new preservation systems.
2. Market Overview
2.1 Market Definition & Scope
Liver preservation systems encompass technologies that maintain organ viability between procurement and transplantation:
Key application segments:
2.2 Market Size & Forecast (2023-2031)
2.3 Key Market Segments
By Preservation Technique:
By Organ Quality:
By Region:
3. Market Dynamics
3.1 Market Drivers
1. Critical Organ Shortage
2. Superior Clinical Outcomes
3. Regulatory Support
4. Technological Convergence
3.2 Market Challenges
1. High System Costs
2. Operational Complexity
3. Evidence Generation
3.3 Market Trends
1. Portable Perfusion Systems
2. Organ Repair Technologies
3. Viability Biomarkers
4. Competitive Landscape
4.1 Market Share Analysis
|
Company |
Market Share |
Key Products |
Strategic Focus |
|
TransMedics |
30% |
OCS Liver System |
Normothermic leadership |
|
OrganOx |
25% |
metra Device |
Clinical evidence generation |
|
Bridge to Life |
20% |
VitaSmart System |
Hypothermic solutions |
|
XVIVO Perfusion |
15% |
XPS System |
Portable technology |
|
Paragonix |
10% |
LIVERguard |
Cold storage innovation |
4.2 Emerging Players
4.3 Recent Developments (2024)
5. Regional Analysis
5.1 North America (XX%)
5.2 Europe (XX%)
5.3 Asia-Pacific (15%)
6. Future Outlook
6.1 Short-Term Projections (2025)
6.2 Medium-Term Outlook (2027)
6.3 Long-Term Forecast (2031)
Need help?
Chat with our team in a minute.